Tyrosine kinase inhibitors for chronic myelogenous leukemia

N Engl J Med. 2007 Oct 11;357(15):1556-7; author reply 1557-8. doi: 10.1056/NEJMc072356.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzamides
  • Fusion Proteins, bcr-abl
  • Humans
  • Hypothyroidism / chemically induced*
  • Imatinib Mesylate
  • Indoles / adverse effects
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / adverse effects
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / adverse effects
  • Pyrroles / adverse effects
  • Sunitinib

Substances

  • Benzamides
  • Indoles
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl
  • Sunitinib